Literature DB >> 20685657

Interferon-gamma-mediated inhibition of serum response factor-dependent smooth muscle-specific gene expression.

Zengdun Shi1, Don C Rockey.   

Abstract

IFNγ exerts multiple biological effects on effector cells by regulating many downstream genes, including smooth muscle-specific genes. However, the molecular mechanisms underlying IFNγ-induced inhibition of smooth muscle-specific gene expression remain unclear. In this study, we have shown that serum response factor (SRF), a common transcriptional factor important in cell proliferation, migration, and differentiation, is targeted by IFNγ in a STAT1-dependent manner. We show that the molecular mechanism by which IFNγ regulates SRF is via activation of the 2-5A-RNase L system, which triggers SRF mRNA decay and reduced SRF expression. As a result, decreased SRF expression reduces expression of SRF target genes such as smooth muscle α-actin and smooth muscle myosin heavy chain. Additionally, IFNγ reduced p300 and acetylated histone-3 binding in both smooth muscle α-actin and SRF promoters, epigenetically decreasing smooth muscle α-actin and SRF transcriptional activation. Our data reveal that SRF is a novel IFNγ-regulated gene and further elucidate the molecular pathway between IFNγ, IFNγ-regulated genes, and SRF and its target genes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685657      PMCID: PMC2952243          DOI: 10.1074/jbc.M110.164863

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.

Authors:  A J Muir; P B Sylvestre; D C Rockey
Journal:  J Viral Hepat       Date:  2006-05       Impact factor: 3.728

Review 2.  The highways and byways of mRNA decay.

Authors:  Nicole L Garneau; Jeffrey Wilusz; Carol J Wilusz
Journal:  Nat Rev Mol Cell Biol       Date:  2007-02       Impact factor: 94.444

3.  Sox15 and Fhl3 transcriptionally coactivate Foxk1 and regulate myogenic progenitor cells.

Authors:  Annette P Meeson; Xiaozhong Shi; Matthew S Alexander; R S Williams; Ronald E Allen; Nan Jiang; Ibrahim M Adham; Sean C Goetsch; Robert E Hammer; Daniel J Garry
Journal:  EMBO J       Date:  2007-03-15       Impact factor: 11.598

Review 4.  Mechanisms of hepatic fibrogenesis.

Authors:  Scott L Friedman
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

Review 5.  Diverse functions of RNase L and implications in pathology.

Authors:  Catherine Bisbal; Robert H Silverman
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

Review 6.  Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus.

Authors:  Joseph M Miano; Xiaochun Long; Keigi Fujiwara
Journal:  Am J Physiol Cell Physiol       Date:  2006-08-23       Impact factor: 4.249

Review 7.  RNase L: its biological roles and regulation.

Authors:  Shu-Ling Liang; David Quirk; Aimin Zhou
Journal:  IUBMB Life       Date:  2006-09       Impact factor: 3.885

8.  TGF-beta up-regulates serum response factor in activated hepatic stellate cells.

Authors:  Jens Herrmann; Ute Haas; Axel M Gressner; Ralf Weiskirchen
Journal:  Biochim Biophys Acta       Date:  2007-11-04

Review 9.  The myofibroblast: one function, multiple origins.

Authors:  Boris Hinz; Sem H Phan; Victor J Thannickal; Andrea Galli; Marie-Luce Bochaton-Piallat; Giulio Gabbiani
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

10.  Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis.

Authors:  Souhila Medjkane; Cristina Perez-Sanchez; Cedric Gaggioli; Erik Sahai; Richard Treisman
Journal:  Nat Cell Biol       Date:  2009-02-08       Impact factor: 28.824

View more
  14 in total

1.  Preproendothelin-1 expression is negatively regulated by IFNγ during hepatic stellate cell activation.

Authors:  Tianxia Li; Zengdun Shi; Don C Rockey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-02       Impact factor: 4.052

2.  Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.

Authors:  Zengdun Shi; Mudan Ren; Don C Rockey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-13       Impact factor: 4.052

3.  Smooth Muscle α-Actin Deficiency Leads to Decreased Liver Fibrosis via Impaired Cytoskeletal Signaling in Hepatic Stellate Cells.

Authors:  Don C Rockey; Qinghong Du; Zengdun Shi
Journal:  Am J Pathol       Date:  2019-08-30       Impact factor: 4.307

Review 4.  The Molecular Basis of Portal Hypertension.

Authors:  Don C Rockey
Journal:  Trans Am Clin Climatol Assoc       Date:  2017

5.  Characterization of focal adhesion proteins in rodent hepatic stellate cells.

Authors:  Nour Hijazi; Zengdun Shi; Don C Rockey
Journal:  Histochem Cell Biol       Date:  2022-08-12       Impact factor: 2.531

Review 6.  Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.

Authors:  Gülsüm Özlem Elpek
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

7.  Fibroblast-specific Stat1 deletion enhances the myofibroblast phenotype during tissue repair.

Authors:  Shayna C Medley; Bharath H Rathnakar; Constantin Georgescu; Jonathan D Wren; Lorin E Olson
Journal:  Wound Repair Regen       Date:  2020-03-24       Impact factor: 3.617

Review 8.  Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.

Authors:  Yasuko Iwakiri; Vijay Shah; Don C Rockey
Journal:  J Hepatol       Date:  2014-06-06       Impact factor: 25.083

9.  RNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative response.

Authors:  Sarah E Brennan-Laun; Xiao-Ling Li; Heather J Ezelle; Thiagarajan Venkataraman; Perry J Blackshear; Gerald M Wilson; Bret A Hassel
Journal:  J Biol Chem       Date:  2014-10-09       Impact factor: 5.157

10.  The mitochondria-targeted antioxidant MitoQ attenuates liver fibrosis in mice.

Authors:  Hasibur Rehman; Qinlong Liu; Yasodha Krishnasamy; Zengdun Shi; Venkat K Ramshesh; Khujista Haque; Rick G Schnellmann; Michael P Murphy; John J Lemasters; Don C Rockey; Zhi Zhong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.